Tofacent 5 mg, containing active Tofacitinib, is a Janus kinase( JAK) asset medicine. It's an vulnerable checkpoint asset that works on certain immunological pathways to dampen inflammation and slacken the progression of some autoimmune conditions. It's primarily indicated for the treatment of relat...